Genetics of hemangiomas, vascular malformations, and primary lymphedema

Journal of Pediatric Hematology/Oncology

Volumn 36, Issue 8, 2014, Pages 587-593

  Blatt, Julie ^a   Powell, Cynthia M ^a   Burkhart, Craig N ^a   Stavas, Joseph ^a   Aylsworth, Arthur S ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Genetics; Hemangioma; Lymphedema; Vascular anomaly; Vascular malformation

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; TRANSCRIPTION FACTOR GATA 2;

CHROMOSOME 3Q; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION; CLINICAL EVALUATION; CONGENITAL BLOOD VESSEL MALFORMATION; GENE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC IDENTIFICATION; HEMANGIOMA; HUMAN; LYMPHEDEMA; MUTATIONAL ANALYSIS; PATIENT ASSESSMENT; PIK3CA GENE; PRACTICE GUIDELINE; REVIEW; RING CHROMOSOME; CHILD; GENETIC PREDISPOSITION; GENETICS; VASCULAR TUMOR;

CHILD; GENETIC PREDISPOSITION TO DISEASE; HEMANGIOMA; HUMANS; LYMPHEDEMA; VASCULAR MALFORMATIONS; VASCULAR NEOPLASMS;

EID: 84918563110     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0000000000000260     Document Type: Review

References (49)

1. Blei F. Peripheral vascular anomalies, malformations, and vascular tumors. In: Creager MA, Beckman JA, Loscalzo J, eds. Vascular Medicine: A Companion to Braunwald's Heart Disease. 2nd ed. Philadelphia: Elsevier; 2013:790-809.
2. Connell F, Gordon K, Brice G, et al. The classification and diagnostic algorithm for primary lymphatic dysplasia: an update from 2010 to include molecular findings. Clin Genet. 2013;84:303-314.
3. Brouillard P, Olsen BR, Vikkula M. High-resolution physical and transcript map of the locus for venous malformations with glomus cells (VMGLOM) on chromosome 1p21-p22. Genomics. 2000;67:96-101.
4. Au AC, Hernandez PA, Lieber E, et al. Protein tyrosine phosphatase PTPN14 is a regulator of lymphatic function and choanal development in humans. Am J Hum Genet. 2010;87:436-444.
5. Ferrell RE, Baty CJ, Kimak MA, et al. GJC2 missense mutations cause human lymphedema. Am J Hum Genet. 2010;86:943-948.
6. Jinnin M, Medici D, Park L, et al. Suppressed NFATdependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma. Nat Med. 2008;14:1236-1246.
7. Pansuriya TC, Van Eijk R, D'Adamo P, et al. Somatic mosaic IDH1 or IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome. Nat Genet. 2011;43:1256-1261.
8. Ostergaard P, Simpson MA, Connell FC, et al. Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome). Nat Genet. 2011;43:929-931.
9. Kazenwadel J, Secker GA, Liu YJ, et al. Loss-of-function germline GATA2 mutations in patients with MDS/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculature. Blood. 2012;119:1283-1291.
10. Tanaka A, Weinel S, Nagy N, et al. Germline mutation in ATR in autosomal-dominant oropharyngeal cancer syndrome. Am J Hum Genet. 2012;90:511-517.
11. Denier C, Labauge P, Bergametti F, et al. Genotype-phenotype correlations in cerebral cavernous malformations patients. Ann Neurol. 2006;60:550-556.
12. Kurek KC, Luks VL, Ayturk UM, et al. Somatic mosaic activating mutations in PIK3CA cause CLOVES syndrome. Am J Hum Genet. 2012;90:1108-1115.
13. Eerola I, Boon LM, Mulliken JB, et al. Capillary malformationarteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations. Am J Hum Genet. 2003;73:1240-1249.
14. Thiex R, Mulliken JB, Revencu N, et al. A novel association between RASA1 mutations and spinal arteriovenous anomalies. Am J Neuroradiol. 2010;31:775-779.
15. Brancati F, Valente EM, Tadini G, et al. Autosomal dominant hereditary benign telangiectasia maps to the CMC1 locus for capillary malformation on chromosome 5q14. J Med Genet. 2003;40:849-853.
16. Walter JW, Blei F, Anderson JL, et al. Genetic mapping of a novel familial form of infantile hemangioma. Am J Med Genet. 1999;82:77-83.
17. Mendola A, Schlögel MJ, Ghalamkarpour A, et al. Mutations in the VEGFR3 signaling pathway explain 36% of familial lymphedema. Mol Syndromol. 2013;4:257-266.
18. Brice G, Ostergaard P, Jeffery S, et al. A novel mutation in GJA1 causing oculodentodigital syndrome and primary lymphoedema in a three generation family. Clin Genet. 2013;84:378-381.
19. Battistini S, Rocchi R, Cerase A, et al. Clinical, magnetic resonance imaging, and genetic study of 5 Italian families with cerebral cavernous malformation. Arch Neurol. 2007;64:843-848.
20. Boon LM, Mulliken JB, Vikkula M, et al. Assignment of a locus for dominantly inherited venous malformations to chromosome 9p. Hum Mol Genet. 1994;3:1583-1587.
21. Shirley MD, Tang H, Gallione CJ, et al. Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ. N Engl J Med. 2013;368:1971-1979.
22. Govani FS, Shovlin CL. Hereditary haemorrhagic telangiectasia: a clinical and scientific review. Eur J Hum Genet. 2009;17:860-871.
23. Marsh DJ, Dahia PLM, Zheng Z, et al. Germline mutations in PTEN are present in Bannayan-Zonana syndrome (letter). Nat Genet. 1997;16:333-334.
24. Ostergaard P, Simpson MA, Mendola A, et al. Mutations in KIF11 cause autosomal dominant microcephaly variably associated with congenital lymphedema and chorioretinopathy. Am J Hum Genet. 2012;90:356-362.
25. Li A, Swift M. Mutations at the ataxia-telangiectasia locus and clinical phenotypes of A-T patients. Am J Med Genet. 2000;92:170-177.
26. Lindhurst MJ, Sapp JC, Teer JK, et al. A mosaic activating mutation in AKT1 associated with the Proteus syndrome. New Engl J Med. 2012;365:611-619.
27. Finegold DN, Kimak MA, Lawrence EC, et al. Truncating mutations in FOXC2 cause multiple lymphedema syndromes. Hum Mol Genet. 2001;10:1185-1189.
28. Hennekam RCM, Geerdink RA, Hamel BCJ, et al. Autosomal recessive intestinal lymphangiectasia and lymphedema, with facial anomalies and mental retardation. Am J Med Genet. 1989;34:593-600.
29. Irrthum A, Devriendt K, Chitayat D, et al. Mutations in the transcription factor gene SOX18 underlie recessive and dominant forms of hypotrichosis-lymphedema-telangiectasia. Am J Hum Genet. 2003;72:1470-1478.
30. Doffinger R, Smahi A, Bessia C, et al. X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappa-B signaling. Nat Genet. 2001;27:277-285.
31. Khonsari RH, Blechman KM, Michaels J, et al. Vascular malformations and upper extremity anomalies associated with a subtelomeric microdeletion of chromosome 4p. Clin Dysmorphol. 2008;17:193-194.
32. Malik S, Grzeschik K-H. Congenital low penetrance lymphedema of lower limbs maps to chromosome 6q16.2-q22.1 in an inbred Pakistani family. Hum Genet. 2008;123:197-205.
33. Mitchell S, Siegel DH, Shieh JT, et al. Candidate locus analysis for PHACE syndrome. Am J Med Genet A. 2012;158A:1363-1367.
34. Wallen KE, Hadar EJ, Perry V, et al. Posterior fossa neoplasm and PHACES syndrome: a case report. J Pediatr Hematol Oncol. 2009;31:203-205.
35. Solomon BD, Lange E, Shubrook J, et al. Deletion of 8q24 in an adult with mild dysmorphic features, developmental delay, and ketotic hypoglycemia. Am J Med Genet A. 2010;152A:1545-1549.
36. Fryns JP. Microcephaly/lymphedema and terminal deletion of the long arm of chromosome 13. Am J Med Genet. 1995;57:504.
37. Bull LN, Roche E, Song EJ, et al. Mapping of the locus for cholestasis-lymphedema syndrome (Aagenaes syndrome) to a 6.6-cM interval on chromosome 15q. Am J Hum Genet. 2000;67:994-999.
38. Blinkenberg EO, Brendehaug A, Sandvik AK, et al. Angioma serpiginosum with oesophageal papillomatosis is an X-linked dominant condition that maps to Xp11.3-Xq12. Eur J Hum Genet. 2007;15:543-547.
39. Boucher CA, Sargent CA, Ogata T, et al. Breakpoint analysis of Turner patients with partial Xp deletions: implications for the lymphoedema gene location. J Med Genet. 2001;38:591-598.
40. Pardo S, Blitman N, Han B, et al. Multiple hemangiomas in a patient with a t (3q;4p) translocation: an infrequent association with Wolf-Hirschhorn syndrome. Am J Med Genet A. 2008;146A:219-224.
41. Whelan AJ, Watson MS, Porter FD, et al. Klippel-Trenaunay-Weber syndrome associated with a 5:11 balanced translocation. Am J Med Genet. 1995;59:492-494.
42. Eisbrenner K, Steffensen TS, Whiteman VE, et al. De novo translocation t (5;9) (q11.2;p22) associated with hydrops fetalis and cystic hygroma. Fetal Pediatr Pathol. 2012;31:39-42.
43. Wang Q, Timur AA, Szafranski P, et al. Identification and molecular characterization of de novo translocation t (8;14) (q22.3;q13) associated with a vascular and tissue overgrowth syndrome. Cytogenet Cell Genet. 2001;95:183-188.
44. Timur AA, Sadgephour A, Graf M, et al. Identification and molecular characterization of a de novo supernumerary ring chromosome 18 in a patient with Klippel-Trenaunay syndrome. Ann Hum Genet. 2004;68:353-361.
45. Duffy K. Genetics and syndromes associated with vascular malformations. Pediatr Clin North Am. 2010;57:1111-1120.
46. Limaye N, Boon L, Vikkula M. From germline towards somatic mutations in the pathophysiologyof vascular anomalies. Hum Mol Gen. 2009;18:R65-R74.
47. Brouillard P, Vikkula M. Genetic causes of vascular malformations. Hum Mol Gen. 2007;16:R140-R149.
48. Soblet J, Limaye N, Uebelhoer M, et al. Variable somatic TIE2 mutations in half of sporadic venous malformations. Mol Syndromol. 2013;4:179-183.
49. Akers AL, Johnson E, Steinberg GK, et al. Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis. Hum Mol Genet. 2009;18:919-930.